-
FDA reaches agreement on medical device user fees
The FDA would be allowed to collect at least $1.78 billion in user fees over five years under a reauthorization of the medical device user fee program, according to a series of recommendations from the agency and representatives from the medical device industry released March 22. -
How hospitals can help ease blood shortages
To help ease chronic blood shortages in the U.S., hospitals should partner with blood centers to increase donations and work with centers to host blood drives, America's Blood Centers said in a March bulletin. -
COVID-19 antibody shipments to be cut by 30%: 6 details
States will see a significant reduction in shipments of COVID-19 monoclonal antibody treatments from the federal government beginning March 21 as the White House's request for $15.6 billion in pandemic funding stalls in Congress, ABC News reported. -
FDA to revive facility visits
The FDA is returning to normal facility inspection operations, which were significantly disrupted by the COVID-19 pandemic, according to a March 21 report from The New York Times. -
Expert insights on navigating 2022 healthcare supply chain trends
After facing many unpredictable supply challenges in the past couple years, it’s important to carry any lessons learned into 2022. In a recent Q&A with Cardinal Health and Becker’s Hospital Review, Joe Walsh, founder of Supply Chain Sherpas, discussed how supply chain leaders can best prepare for the year ahead. -
4 rapid COVID-19 test recalls announced by FDA this week
The FDA recently posted recall notices for four rapid COVID-19 tests recalled since Jan. 13. -
Inventory of scarce COVID-19 antibody drops further
Several hundred providers of Evusheld, a COVID-19 antibody treatment for immunocompromised, were removed from a federal dataset March 16, making it even more difficult to locate the therapy, Kaiser Health News reported March 17. -
4 recent medical device recalls
Medical device recalls, whether voluntary or mandated by the FDA, ensure patient safety. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
$350M nitrile glove plant coming to Maryland
A new $350 million medical manufacturing facility producing nitrile gloves is set to be built in Baltimore County, Maryland, according to a March 16 news release from the manufacturer. -
Cleveland Clinic, Johns Hopkins among health systems, organizations sending supplies to Ukraine
The images and reports from the war in Ukraine have moved several health systems to action, donating their own medical supplies and medicines to be sent to the war-torn nation. -
China's worst COVID-19 surge since 2020 poised to further disrupt global supply chains
China's "zero tolerance" approach to COVID-19 outbreaks has led to measures to curb its worst surge since 2020 that will further disrupt global supply chains, The New York Times reported March 15. -
Supply Chain Tip of the Week: Integrate technology into your 2022 supply chain strategy
In today’s age of unpredictability in the healthcare supply chain industry, taking proactive steps to manage backorders, gain visibility, and implement contingency scenarios is what can set you apart in the industry. -
Baxter recalls infusion pumps over alarm failure
Baxter recalled over 277,000 infusion pumps due to the risk of the device failing to alarm users of repeated upstream occlusion events. -
Acon Laboratories recalls non-authorized COVID-19 tests
Acon Laboratories has recalled unauthorized and misbranded counterfeit COVID-19 at-home testing kits. -
FDA orders Philips to notify customers of ventilator recall
The FDA on March 10 issued a notification order to Philips Respironics requiring the company to notify all customers of the company’s June 14 recall of certain Philips Respironics ventilators. -
US-Mexico border policy may spur plasma shortage
Some patient advocacy groups are voicing concerns that a federal policy blocking Mexican nationals from entering the U.S. to donate plasma could cause shortages of critical drugs used to treat neurological and autoimmune diseases, The Wall Street Journal reported March 9. -
American Nitrile secures funding for Ohio plant
Columbus, Ohio-based American Nitrile will receive $105 million in debt financing to aid in the completion of a new glove manufacturing plant in Grove City, the Columbus Dispatch reported March 9. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
Fast Company's 10 most innovative medical devices of 2022
Fast Company on March 8 released its 2022 list of "Most Innovative Medical Device Companies."
Page 41 of 50